Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases.
Authors:
- L MouthonLML Mouthon
- M D KazatchkineMKM D Kazatchkine
Open Access
- 1 November 1994
- journal article
- review article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 57 (Suppl) , 6-8
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Selection of the expressed B cell repertoire by infusion of normal immunoglobulin G in a patient with autoimmune thyroiditisEuropean Journal of Immunology, 1993
- Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg)Clinical and Experimental Immunology, 1993
- On the mechanism of high-dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathyJournal of Neuroimmunology, 1990
- Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model.Journal of Clinical Investigation, 1989
- Anti‐idiotypes against Autoantibodies in Normal Immunoglobulins: Evidence for Network Regulation of Human Autoimmune ResponsesImmunological Reviews, 1989
- Treatment of Refractory Immune Thrombocytopenic Purpura with an Anti-Fcγ-Receptor AntibodyNew England Journal of Medicine, 1986
- In vivo Reduction of Circulating C1q Binding Immune Complexes by Intravenous Gammaglobulin AdministrationInternational Archives of Allergy and Immunology, 1986
- Effect of intravenous immune globulin on natural killer cell activity: Possible association with autoimmune neutropenia and idiopathic thrombocytopeniaThe Journal of Pediatrics, 1986
- EFFECT OF INTRAVENOUS IMMUNOGLOBULIN IN IMMUNE THROMBOCYTOPENIAThe Lancet, 1983
- Transient Reversal of Thrombocytopenia in Idiopathic Thrombocytopenic Purpura by High-Dose Intravenous Gamma GlobulinNew England Journal of Medicine, 1982